News

Business Insider4y
Nanoform launches next-generation STARMAP® v2.0, the AI-based drug candidate selection tool for CESS®
HELSINKI, March 22, 2021 /PRNewswire/ -- Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, has today launched the next generation of its STARMAP ® AI (artificial ...
Business Insider4y
Nanoform makes US TV debut in Advancements with Ted Danson (CNBC)
HELSINKI, Dec. 2, 2020 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, will be featured in an upcoming Advancements episode broadcasting ...
Yahoo Finance1y
Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide
HELSINKI, Jan. 5, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance enhancing company, today announced it had completed the First Subject First Visit (FSFV ...
PR Newswire1y
Nanoform's biologics technology showcased by large pharma at drug delivery conference; Nanoenzalutamide and nanoapalutamide partnering discussions progress as planned
We expect nanoenzalutamide to be the first nanoformed medicine to reach the market - with a planned launch in 2027/28 in the US/EU - and to be a revenue driver for Nanoform already in the upcoming ...
Pharmabiz1y
Nanoform begins relative bioavailability study of nanotechnology-enhanced enzalutamide
Nanoform Finland Plc (Nanoform), the medicine performance enhancing company, announced it had completed the First Subject First Visit (FSFV) in a trial to evaluate the relative bioavailability of its ...